An observational target trial emulation using the MIMIC-IV database links baseline blood-count markers to which septic shock patients may benefit from corticosteroids. Researchers report that lower absolute lymphocyte counts plus higher neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios—patterns consistent with suppressed adaptive immunity—correlated with reduced ICU mortality when treated with corticosteroids. The analysis used Augmented Inverse Probability Weighting with double-robust estimation to adjust for baseline imbalances, addressing longstanding discordance across prior randomized trials such as CAPE-COD and REMAP-CAP. The work frames patient heterogeneity as central to finding responsive endotypes rather than broadly treating all comers. Clinically, the appeal is that the marker inputs come from routine complete blood counts available in virtually every critical care setting, enabling stratification without additional assays.